Commercial framework: working in partnership with the pharmaceutical industry for the benefit of patients

The NHS in England spends around £18 billion on medicines a year. It must do everything it can to get access to innovative medicines for patients, while making sure it does so at great value and cost-effective prices to the NHS and taxpayers, writes Blake Dark, commercial medicines director for NHS England Related items fromOnMedica Pharmacists could offer high-dose statins direct to patients Clinicians need better options if we are to stop over-medication GPs need more time to treat complex needs Stroke survivors need more help taking medicine Prescription drug dependence linked to deprivation
Source: OnMedica Views - Category: Primary Care Source Type: news